Cargando…
Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables
Non-alcoholic fatty liver disease (NAFLD) has a prevalence of approximately 30% in western countries, and is emerging as the first cause of liver cirrhosis and hepatocellular carcinoma (HCC). Therefore, risk stratification emerges as fundamental in order to optimize human and economic resources, and...
Autores principales: | Vespasiani-Gentilucci, Umberto, Gallo, Paolo, Dell’Unto, Chiara, Volpentesta, Mara, Antonelli-Incalzi, Raffaele, Picardi, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250919/ https://www.ncbi.nlm.nih.gov/pubmed/30487694 http://dx.doi.org/10.3748/wjg.v24.i43.4835 |
Ejemplares similares
-
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination
por: Galati, Giovanni, et al.
Publicado: (2014) -
Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2018) -
Exhaled breath analysis in hepatology: State-of-the-art and perspectives
por: De Vincentis, Antonio, et al.
Publicado: (2019) -
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study
por: De Vincentis, Antonio, et al.
Publicado: (2016) -
The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2016)